Health-care companies rose as some beaten-down firms rebounded.

NEW YORK — Wall Street rolled to more records on Thursday as Nvidia and Intel led a rally for technology stocks after ...

The two observational studies have limitations, including use of older GLP-1s, but still point to the strengths of bariatric ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

It’s unclear how much such a pill would cost, but Novo Nordisk’s Ozempic and Wegovy shots currently go for several hundred ...

Novo Nordisk's Wegovy will soon come in a pill form that's as effective as with a needle. A new study shows Wegovy taken once ...

Medicare and Medicaid coverage of GLP-1 weight loss drugs could be just what the doctor ordered for these two struggling ...

Wegovy maker Novo Nordisk has cut a U.S. sales team focused on obesity and diabetes education for healthcare providers, ...

CNBC's Angelica Peebles reports on Novo Nordisk shares surging after the company announced that its Wegovy pill trial showed ‘significant’ weight reduction.

The European Union is weighing a plan to use frozen Russian assets to back a so-called “reparation loan” for Ukraine, as per ...

Novo Nordisk A/S (NYSE: NVO) is one of the best beginner stocks to buy, according to analysts. On September 17, Berenberg ...

Nvov Nordisk stock rose after a study showed Ozempic reduced the risk of heart attack, stroke and death by 23% compared with ...